Deferoxamine, CAS [[70-51-9]]

Produktübersicht

• Artikelname: Deferoxamine, CAS [[70-51-9]]
• Artikelnummer: MCE-HY-B1625
• Hersteller Artikelnummer: HY-B1625
• Alternativnummer: MCE-HY-B1625-100MG,MCE-HY-B1625-5MG,MCE-HY-B1625-50MG,MCE-HY-B1625-1MG,MCE-HY-B1625-10MMX1ML,MCE-HY-B1625-10MG,MCE-HY-B1625-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Deferoxamine B, Deferriferrioxamine B, Deferrioxamine

Produktbeschreibung

Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1alpha levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].

Produkteigenschaften

• Molekulargewicht: 560.68
• Reinheit: 99.76
• CAS Nummer: [70-51-9]
• Formel: C25H48N6O8
• Target-Kategorie: Akt,Apoptosis,Autophagy,HIF/HIF Prolyl-Hydroxylase,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound